Publications Board Minutes Agendas Newsletters Guidance Documents Reports News Releases Guidance Documents General Information Compounding Terminal Distributor Requirements for Prescribers Possessing Compounded Drugs or Engaging in Drug CompoundingCompounding in OhioDrugs Compounded in a Pharmacy Must Adhere to the U.S. Pharmacopeia Conv...Ohio Licensed Outsourcing FacilitiesCompounding for Drug ShortagesClarification on Dilution or Reconstitution of Allergen ExtractsRegistering as a 503B Outsourcing FacilityHazardous Drug Compounding by Prescribers Consult Agreements Pharmacist Consult Agreement with Physicians Controlled Substances Prescribing Qsymia® and Belviq® for Chronic Weight Management For Prescribers - New Limits on Prescription Opioids for Acute PainFor Pharmacists - New Limits on Prescription Opioids for Acute PainPrescibing Opioids to MinorsDiagnosis Code Prescription Requirement - ResolutionNew Requirements for Opioid Prescriptions - Effective 4.6.2017Clarification on Transfer of Unfilled Controlled Substance PrescriptionsShort-term Weight Loss Anorexiants FAQChanges in Ohio Law Impacting Buprenorphine Used for the Purpose of Treating Drug Dependence or AddictionControlled Substance Inventory RequirementsRescheduling of Hydrocodone Combination Products Effective October 6, 2014Tramadol is a Schedule IV Controlled Substance - Effective August 18. 2014 Dangerous Drugs Point of Dispensing Locations in a Declared Public Health EmergencyAddressing Possible Shortages of Oseltamivir Products Used to Treat InfluenzaIssuing a Valid Prescription - What Every Prescriber Needs to KnowDispensing of Emergency Refill of Medication without a PrescriptionAdministration of Injections by PharmacistsDispensing Multiple Simultaneous Refills of PrescriptionsExpedited Partner Therapy (EPT)Storage of Records Outside of the Pharmacy DepartmentReporting Theft or Loss of Dangerous Drugs and Prescription Drug DocumentsDelivery of Non-Self Injectable DrugsProcurement of Epinephrine Autoinjectors by Schools and Camps Drug Repository Programs Drugs Collected by a Drug Repository Program Drug Disposal Drug Disposal Resources Correctional Facility Destruction of Patient-Specific Controlled SubstancesControlled Substance Inventory DisposalDrug Enforcement Administration Releases New Rules on Pharmaceutical Drug Collection Electronic Prescribing Approval of Electronic Prescription Transmission Systems & Computerized Prescriber Order Entry SystemsNew Guidance - Printing of Electronic Prescriptions Emergency Medical Services Emergency Medical Services - Frequently Asked QuestionsOccasional Wholesale Sales by EMS Agencies in the Event of a Drug Shortage Human Trafficking Everyone has a Role in Ending Human Trafficking Pharmacist Continuing Education Course on Human Trafficking Immunizations Guidance Document - Immunizations by Pharmacists and Pharmacy InternsApproved Immunization CoursesPharmacist Use of the Ohio Impact Statewide Immunization Information System Medical Marijuana Control Program CBD Oil FAQClarification on CBD OilLicensee Participation in the Ohio Medical Marijuana Control Program Naloxone Naloxone Resources Ohio Automated Rx Reporting System OARRS Rules & Corresponding Responsibility DEA Plus Suffix Upload InstructionsReporting Gabapentin Products to OARRS – Effective 12-1-2016H.B. 341 - Mandatory OARRS Registration and RequestsOARRS Integration Fact SheetCoroner Use of the Ohio Automated Rx Reporting System Pain Management Clinics Responsible Person Requirements for Pain Management Clinics Positive Identification Positive Identification for EMSPositive Identification And Hospital Electronic Drug Record Keeping Systems Protocols Influenza Outbreak Management in Long-Term Care Facilities by Emergency ProtocolJoint Regulatory Statement - Use of Protocols to Initiate or Adjust Medications